UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 68.60
-0.70 (-1.01%)
Oct 20, 2026, 1:30 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 4.37 billion as of October 20, 2026. It is the 23,239th most valuable company in the world and the 1,182nd biggest in Taiwan. Its market cap has increased by 2.48% in one year.
Market Cap
4.37B
Enterprise Value
3.72B
Revenue
22.46M
Global Rank
Country Rank
#1,182 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 4.37B, an increase of 152.64%. That is a compound annual growth rate of 17.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 4.37B | -19.71% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medigen Biotechnology | 4.95B |
| Mycenax Biotech | 4.80B |
| BRIM Biotechnology | 4.47B |
| Sunhawk Vision Biotech | 4.36B |
| Sinew Pharma | 4.26B |
| Formosa Pharmaceuticals | 3.83B |
| Pharmosa Biopharm | 3.61B |
| SYN-TECH Chem. & Pharm. | 3.42B |